Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds

Remdesivir may be effective in reducing recovery time of patients with severe covid-19, although the certainty of the evidence is low, a panel of international experts has concluded.1

As part of The BMJ’s Rapid Recommendations initiative, the panel reviewed new evidence and made a weak recommendation for the use of the antiviral drug for patients with severe covid-19. They strongly supported continued enrolment of patients into ongoing clinical trials.

However, the panel also advised caution over the potential opportunity cost of using remdesivir …